Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer

Sara Arranz, Gemma Chiva-Blanch, Palmira Valderas-Martínez, Alex Medina-Remón, Rosa M Lamuela-Raventós, Ramón Estruch, Sara Arranz, Gemma Chiva-Blanch, Palmira Valderas-Martínez, Alex Medina-Remón, Rosa M Lamuela-Raventós, Ramón Estruch

Abstract

Since ancient times, people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer, often without any scientific basis. There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality, as well as with work related and traffic accidents. On the contrary, at the moment, several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality, mainly from coronary diseases. However, there are discrepancies regarding the specific effects of different types of beverages (wine, beer and spirits) on the cardiovascular system and cancer, and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content (ethanol) or to their non-alcoholic components (mainly polyphenols). Epidemiological and clinical studies have pointed out that regular and moderate wine consumption (one to two glasses a day) is associated with decreased incidence of cardiovascular disease (CVD), hypertension, diabetes, and certain types of cancer, including colon, basal cell, ovarian, and prostate carcinoma. Moderate beer consumption has also been associated with these effects, but to a lesser degree, probably because of beer's lower phenolic content. These health benefits have mainly been attributed to an increase in antioxidant capacity, changes in lipid profiles, and the anti-inflammatory effects produced by these alcoholic beverages. This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components, alcohol and polyphenols.

Keywords: alcohol; beer; cancer; cardiovascular disease; polyphenols; wine.

References

    1. Willett W.C., Sacks F., Trichopoulou A., Drescher G., Ferro-Luzzi A., Helsing E., Trichopoulos D. Mediterranean diet pyramid: A cultural model for healthy eating. Am. J. Clin. Nutr. 1995;61:1402S–1406S.
    1. Lindberg M.L., Amsterdam E.A. Alcohol, wine, and cardiovascular health. Clin. Cardiol. 2008;31:347–351. doi: 10.1002/clc.20263.
    1. Friedman L.A., Kimball A.W. Coronary heart disease mortality and alcohol consumption in framingham. Am. J. Epidemiol. 1986;124:481–489.
    1. Muntwyler J., Hennekens C.H., Buring J.E., Gaziano J.M. Mortality and light to moderate alcohol consumption after myocardial infarction. Lancet. 1998;352:1882–1885.
    1. Gronbaek M., Deis A., Sorensen T.I., Becker U., Schnohr P., Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. BMJ. 1995;310:1165–1169. doi: 10.1136/bmj.310.6988.1165.
    1. Estruch R., Nicolas J.M., Villegas E., Junque A., Urbano-Marquez A. Relationship between ethanol-related diseases and nutritional status in chronically alcoholic men. Alcohol Alcohol. 1993;28:543–550.
    1. Brien S.E., Ronksley P.E., Turner B.J., Mukamal K.J., Ghali W.A. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: Systematic Review and meta-analysis of interventional studies. BMJ. 2011;342:d636.
    1. Ronksley P.E., Brien S.E., Turner B.J., Mukamal K.J., Ghali W.A. Association of alcohol consumption with selected cardiovascular disease outcomes: A systematic review and meta-analysis. BMJ. 2011;342:d671.
    1. Di Castelnuovo A., Costanzo S., Bagnardi V., Donati M.B., Iacoviello L., de Gaetano G. Alcohol dosing and total mortality in men and women: An updated meta-analysis of 34 prospective studies. Arch. Intern. Med. 2006;166:2437–2445. doi: 10.1001/archinte.166.22.2437.
    1. Rimm E.B., Giovannucci E.L., Willett W.C., Colditz G.A., Ascherio A., Rosner B., Stampfer M.J. Prospective Study of alcohol consumption and risk of coronary disease in men. Lancet. 1991;338:464–468.
    1. Mukamal K.J., Jensen M.K., Gronbaek M., Stampfer M.J., Manson J.E., Pischon T., Rimm E.B. Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men. Circulation. 2005;112:1406–1413. doi: 10.1161/CIRCULATIONAHA.105.537704.
    1. Djousse L., Gaziano J.M. Alcohol consumption and heart failure: A systematic review. Curr. Atheroscler. Rep. 2008;10:117–120. doi: 10.1007/s11883-008-0017-z.
    1. Vinson J.A., Mandarano M., Hirst M., Trevithick J.R., Bose P. Phenol antioxidant quantity and quality in foods: beers and the effect of two types of beer on an animal model of atherosclerosis. J. Agric. Food Chem. 2003;51:5528–5533. doi: 10.1021/jf034189k.
    1. Ramos S. Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways. Mol. Nutr. Food Res. 2008;52:507–526. doi: 10.1002/mnfr.200700326.
    1. Palmieri D., Pane B., Barisione C., Spinella G., Garibaldi S., Ghigliotti G., Brunelli C., Fulcheri E., Palombo D. Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development. J. Surg. Res. 2011;171:e237–e246. doi: 10.1016/j.jss.2011.07.041.
    1. Bhatt S.R., Lokhandwala M.F., Banday A.A. Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats. Eur. J. Pharmacol. 2011;667:258–264. doi: 10.1016/j.ejphar.2011.05.026.
    1. Crescente M., Jessen G., Momi S., Holtje H.D., Gresele P., Cerletti C., de Gaetano G. Interactions of gallic acid, resveratrol, quercetin and aspirin at the platelet cyclooxygenase-1 leve. Functional and modelling studies. Thromb. Haemost. 2009;102:336–346.
    1. Renaud S., de Lorgeril M. Wine, alcohol, platelets, and the french paradox for coronary heart disease. Lancet. 1992;339:1523–1526. doi: 10.1016/0140-6736(92)91277-F.
    1. Rimm E.B. Alcohol consumption and coronary heart disease: Good habits may be more important than just good wine. Am. J. Epidemiol. 1996;143:1094–1098. doi: 10.1093/oxfordjournals.aje.a008684.
    1. Ruf J.C. Overview of epidemiological studies on wine, health and mortality. Drugs Exp. Clin. Res. 2003;29:173–179.
    1. Estruch R., Lamuela-Raventos R.M. Alcohol, wine and cardiovascular disease, two sides of the same coin. Intern. Emerg. Med. 2010;5:277–279. doi: 10.1007/s11739-010-0391-8.
    1. Gorinstein S., Caspi A., Libman I., Leontowicz H., Leontowicz M., Tashma Z., Katrich E., Jastrzebski Z., Trakhtenberg S. Bioactivity of beer and its influence on human metabolism. Int. J. Food Sci. Nutr. 2007;58:94–107. doi: 10.1080/09637480601108661.
    1. Gerhauser C. Beer constituents as potential cancer chemopreventive agents. Eur. J. Cancer. 2005;41:1941–1954. doi: 10.1016/j.ejca.2005.04.012.
    1. Chung W.G., Miranda C.L., Stevens J.F., Maier C.S. Hop Proanthocyanidins induce apoptosis, protein carbonylation, and cytoskeleton disorganization in human colorectal adenocarcinoma cells via reactive oxygen species. Food Chem. Toxicol. 2009;47:827–836. doi: 10.1016/j.fct.2009.01.015.
    1. Gerhauser C., Alt A., Heiss E., Gamal-Eldeen A., Klimo K., Knauft J., Neumann I., Scherf H.R., Frank N., Bartsch H., et al. Cancer chemopreventive activity of xanthohumol, a natural product derived from hop. Mol. Cancer. Ther. 2002;1:959–969.
    1. Milligan S.R., Kalita J.C., Pocock V., Van De Kauter V., Stevens J.F., Deinzer M.L., Rong H., de Keukeleire D. The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. J. Clin. Endocrinol. Metab. 2000;85:4912–4915.
    1. Tobe H., Muraki Y., Kitamura K., Komiyama O., Sato Y., Sugioka T., Maruyama H.B., Matsuda E., Nagai M. Bone resorption inhibitors from hop extract. Biosci. Biotechnol. Biochem. 1997;61:158–159. doi: 10.1271/bbb.61.158.
    1. Wang Q., Ding Z.H., Liu J.K., Zheng Y.T. Xanthohumol, a novel anti-HIV-1 agent purified from hops Humulus lupulus. Antiviral Res. 2004;64:189–194.
    1. Waterhouse A.L. Wine Phenolics. Ann. N. Y. Acad. Sci. 2002;957:21–36. doi: 10.1111/j.1749-6632.2002.tb02903.x.
    1. Vinson J.A., Jang J., Dabbagh Y.A., Serry M.M., Cai S. Plant polyphenols exhibit lipoprotein-bound antioxidant activity using an in vitro oxidation model for heart disease. J. Agric. Food Chem. 1995;43:2798–2799. doi: 10.1021/jf00059a004.
    1. Brown L., Kroon P.A., Das D.K., Das S., Tosaki A., Chan V., Singer M.V., Feick P. The biological responses to resveratrol and other polyphenols from alcoholic beverages. Alcohol. Clin. Exp. Res. 2009;33:1513–1523. doi: 10.1111/j.1530-0277.2009.00989.x.
    1. Nassiri-Asl M., Hosseinzadeh H. Review of the pharmacological effects of Vitis vinifera (grape) and its bioactive compounds. Phytother. Res. 2009;23:1197–1204. doi: 10.1002/ptr.2761.
    1. Neveu V., Perez-Jimenez J., Vos F., Crespy V., du Chaffaut L., Mennen L., Knox C., Eisner R., Cruz J., Wishart D., et al. Phenol-explorer: An online comprehensive database on polyphenol contents in foods. Database (Oxf.) 2010;2010:ap024.
    1. Estruch R., Urpi-Sarda M., Chiva G., Romero E.S., Covas M.I., Salas-Salvadó J., Wärnberg J., Lamuela-Raventós R.M. Cerveza, Dieta Mediterránea y Enfermedad Cardiovascular. Centro de Información Cerveza y Salud; Madrid, Spain: 2011. pp. 1–81.
    1. Taylor A.W., Barofsky E., Kennedy J.A., Deinzer M.L. Hop (Humulus lupulus L.) proanthocyanidins characterized by mass spectrometry, acid catalysis, and gel permeation chromatography. J. Agric. Food Chem. 2003;51:4101–4110.
    1. De Keukeleire D., de Cooman L., Rong H., Heyerick A., Kalita J., Milligan S.R. Functional properties of hop polyphenols. Basic Life Sci. 1999;66:739–760.
    1. Klatsky A.L. Alcohol and cardiovascular health. Physiol. Behav. 2010;100:76–81. doi: 10.1016/j.physbeh.2009.12.019.
    1. Rimm E.B., Williams P., Fosher K., Criqui M., Stampfer M.J. Moderate alcohol intake and lower risk of coronary heart disease: Meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999;319:1523–1528.
    1. Gaziano J.M., Buring J.E., Breslow J.L., Goldhaber S.Z., Rosner B., VanDenburgh M., Willett W., Hennekens C.H. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N. Engl. J. Med. 1993;329:1829–1834.
    1. Magnus P., Bakke E., Hoff D.A., Hoiseth G., Graff-Iversen S., Knudsen G.P., Myhre R., Normann P.T., Naess O., Tambs K., et al. Controlling for high-density lipoprotein cholesterol does not affect the magnitude of the relationship between alcohol and coronary heart disease. Circulation. 2011;124:2296–2302.
    1. Schroder H., Marrugat J., Fito M., Weinbrenner T., Covas M.I. Alcohol consumption is directly associated with circulating oxidized low-density lipoprotein. Free Radic. Biol. Med. 2006;40:1474–1481. doi: 10.1016/j.freeradbiomed.2005.12.014.
    1. Yoshida R., Shioji I., Kishida A., Ogawa Y. Moderate alcohol consumption reduces urinary 8-hydroxydeoxyguanosine by inducing of uric acid. Ind. Health. 2001;39:322–329. doi: 10.2486/indhealth.39.322.
    1. Barden A., Zilkens R.R., Croft K., Mori T., Burke V., Beilin L.J., Puddey I.B. A reduction in alcohol consumption is associated with reduced plasma F2-isoprostanes and urinary 20-HETE excretion in men. Free Radic. Biol. Med. 2007;42:1730–1735. doi: 10.1016/j.freeradbiomed.2007.03.004.
    1. Bertelli A.A. Wine, Research and cardiovascular disease: Instructions for use. Atherosclerosis. 2007;195:242–247. doi: 10.1016/j.atherosclerosis.2007.04.006.
    1. Covas M.I. The Mediterranean Diet and the Contribution and Role of Alcohol. In: Preedy V.R., Watson R.R., editors. Comprehensive Handbook of Alcohol Related Pathology. Vol. 1. Elsevier Academic Press; San Diego, CA, USA: 2004. pp. 135–146. Chapter 12.
    1. Estruch R., Sacanella E., Mota F., Chiva-Blanch G., Antunez E., Casals E., Deulofeu R., Rotilio D., Andres-Lacueva C., Lamuela-Raventos R.M., et al. Moderate consumption of red wine, but not gin, decreases erythrocyte superoxide dismutase activity: A randomised cross-over trial. Nutr. Metab. Cardiovasc. Dis. 2011;21:46–53. doi: 10.1016/j.numecd.2009.07.006.
    1. Foerster M., Marques-Vidal P., Gmel G., Daeppen J.B., Cornuz J., Hayoz D., Pecoud A., Mooser V., Waeber G., Vollenweider P., et al. Alcohol drinking and cardiovascular risk in a population with high mean alcohol consumption. Am. J. Cardiol. 2009;103:361–368. doi: 10.1016/j.amjcard.2008.09.089.
    1. Hendriks H.F., Veenstra J., Velthuis-te Wierik E.J., Schaafsma G., Kluft C. Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. BMJ. 1994;308:1003–1006.
    1. Koppes L.L., Dekker J.M., Hendriks H.F., Bouter L.M., Heine R.J. Moderate alcohol consumption lowers the risk of type 2 diabetes: A meta-analysis of prospective observational studies. Diabetes Care. 2005;28:719–725. doi: 10.2337/diacare.28.3.719.
    1. Davies M.J., Baer D.J., Judd J.T., Brown E.D., Campbell W.S., Taylor P.R. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: A randomized controlled trial. JAMA. 2002;287:2559–2562.
    1. Fu W., Conklin B.S., Lin P.H., Lumsden A.B., Yao Q., Chen C. Red wine prevents homocysteine-induced endothelial dysfunction in porcine coronary arteries. J. Surg. Res. 2003;115:82–91. doi: 10.1016/S0022-4804(03)00247-6.
    1. Booyse F.M., Pan W., Grenett H.E., Parks D.A., Darley-Usmar V.M., Bradley K.M., Tabengwa E.M. Mechanism by which alcohol and wine polyphenols affect coronary heart disease risk. Ann. Epidemiol. 2007;17:S24–S31. doi: 10.1016/j.annepidem.2007.01.006.
    1. Di Castelnuovo A., Rotondo S., Iacoviello L., Donati M.B., de Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation. 2002;105:2836–2844. doi: 10.1161/01.CIR.0000018653.19696.01.
    1. Costanzo S., Di Castelnuovo A., Donati M.B., Iacoviello L., de Gaetano G. Wine, beer or spirit drinking in relation to fatal and non-fatal cardiovascular events: A meta-analysis. Eur. J. Epidemiol. 2011;26:833–850. doi: 10.1007/s10654-011-9631-0.
    1. Di Castelnuovo A., Costanzo S., di Giuseppe R., de Gaetano G., Iacoviello L. Alcohol consumption and cardiovascular risk: Mechanisms of action and epidemiologic perspectives. Future Cardiol. 2009;5:467–477. doi: 10.2217/fca.09.36.
    1. Gresele P., Cerletti C., Guglielmini G., Pignatelli P., de Gaetano G., Violi F. Effects of resveratrol and other wine polyphenols on vascular function: An update. J. Nutr. Biochem. 2011;22:201–211. doi: 10.1016/j.jnutbio.2010.07.004.
    1. Piazzon A., Forte M., Nardini M. Characterization of phenolics content and antioxidant activity of different beer types. J. Agric. Food Chem. 2010;58:10677–10683. doi: 10.1021/jf101975q.
    1. Martinez N., Urpi-Sarda M., Martinez-Gonzalez M.A., Andres-Lacueva C., Mitjavila M.T. Dealcoholised beers reduce atherosclerosis and expression of adhesion molecules in apoE-deficient mice. Br. J. Nutr. 2011;105:721–730. doi: 10.1017/S0007114510004289.
    1. Di Castelnuovo A., Costanzo S., Donati M.B., Iacoviello L., de Gaetano G. Prevention of cardiovascular risk by moderate alcohol consumption: epidemiologic evidence and plausible mechanisms. Intern. Emerg. Med. 2010;5:291–297. doi: 10.1007/s11739-010-0346-0.
    1. Estruch R., Sacanella E., Badia E., Antunez E., Nicolas J.M., Fernandez-Sola J., Rotilio D., de Gaetano G., Rubin E., Urbano-Marquez A. Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: A prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis. 2004;175:117–123. doi: 10.1016/j.atherosclerosis.2004.03.006.
    1. Renaud S.C., Gueguen R., Siest G., Salamon R. Wine, beer, and mortality in middle-aged men from eastern france. Arch. Intern. Med. 1999;159:1865–1870. doi: 10.1001/archinte.159.16.1865.
    1. Fuchs C.S., Stampfer M.J., Colditz G.A., Giovannucci E.L., Manson J.E., Kawachi I., Hunter D.J., Hankinson S.E., Hennekens C.H., Rosner B. Alcohol consumption and mortality among women. N. Engl. J. Med. 1995;332:1245–1250.
    1. van der Gaag M.S., van Tol A., Scheek L.M., James R.W., Urgert R., Schaafsma G., Hendriks H.F. Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men. Atherosclerosis. 1999;147:405–410. doi: 10.1016/S0021-9150(99)00243-9.
    1. Hvidtfeldt U.A., Tolstrup J.S., Jakobsen M.U., Heitmann B.L., Gronbaek M., O’Reilly E., Balter K., Goldbourt U., Hallmans G., Knekt P., et al. Alcohol intake and risk of coronary heart disease in younger, middle-aged, and older adults. Circulation. 2010;121:1589–1597.
    1. Johansen D., Friis K., Skovenborg E., Gronbaek M. Food buying habits of people who buy wine or beer: Cross sectional study. BMJ. 2006;332:519–522. doi: 10.1136/bmj.38694.568981.80.
    1. Ross R. Atherosclerosis-an Inflammatory disease. N. Engl. J. Med. 1999;340:115–126. doi: 10.1056/NEJM199901143400207.
    1. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868–874. doi: 10.1038/nature01323.
    1. Maseri A., Fuster V. Is there a vulnerable plaque? Circulation. 2003;107:2068–2071. doi: 10.1161/01.CIR.0000070585.48035.D1.
    1. De Rijke Y.B., Demacker P.N., Assen N.A., Sloots L.M., Katan M.B., Stalenhoef A.F. Red wine consumption does not affect oxidizability of low-density lipoproteins in volunteers. Am. J. Clin. Nutr. 1996;63:329–334.
    1. Fuhrman B., Lavy A., Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am. J. Clin. Nutr. 1995;61:549–554.
    1. Badia E., Sacanella E., Fernandez-Sola J., Nicolas J.M., Antunez E., Rotilio D., de Gaetano G., Urbano-Marquez A., Estruch R. Decreased tumor necrosis factor-induced adhesion of human monocytes to endothelial cells after moderate alcohol consumption. Am. J. Clin. Nutr. 2004;80:225–230.
    1. Imhof A., Blagieva R., Marx N., Koenig W. Drinking modulates monocyte migration in healthy subjects: A randomised intervention study of water, ethanol, red wine and beer with or without alcohol. Diab. Vasc. Dis. Res. 2008;5:48–53. doi: 10.3132/dvdr.2008.009.
    1. Chiva-Blanch G., Urpi-Sarda M., Llorach R., Rotches-Ribalta M., Guillen M., Casas R., Arranz S., Valderas-Martinez P., Portoles O., Corella D., et al. Differential effects of polyphenols and alcohol of red wine on the expression of adhesion molecules and inflammatory cytokines related to atherosclerosis: A randomized clinical trial. Am. J. Clin. Nutr. 2012;95:326–334. doi: 10.3945/ajcn.111.022889.
    1. Sacanella E., Vazquez-Agell M., Mena M.P., Antunez E., Fernandez-Sola J., Nicolas J.M., Lamuela-Raventos R.M., Ros E., Estruch R. Down-regulation of adhesion molecules and other inflammatory biomarkers after moderate wine consumption in healthy women: A randomized trial. Am. J. Clin. Nutr. 2007;86:1463–1469.
    1. Williamson G., Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am. J. Clin. Nutr. 2005;81:243S–255S.
    1. Donovan J.L., Bell J.R., Kasim-Karakas S., German J.B., Walzem R.L., Hansen R.J., Waterhouse A.L. Catechin is present as metabolites in human plasma after consumption of red wine. J. Nutr. 1999;129:1662–1668.
    1. Bell J.R., Donovan J.L., Wong R., Waterhouse A.L., German J.B., Walzem R.L., Kasim-Karakas S.E. (+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine. Am. J. Clin. Nutr. 2000;71:103–108.
    1. Donovan J.L., Kasim-Karakas S., German J.B., Waterhouse A.L. Urinary excretion of catechin metabolites by human subjects after red wine consumption. Br. J. Nutr. 2002;87:31–37. doi: 10.1079/BJN2001482.
    1. Lapidot T., Harel S., Granit R., Kanner J. Bioavailability of red wine anthocyanins as detected in human urine. J. Agric. Food Chem. 1998;46:4297–4302. doi: 10.1021/jf980007o.
    1. Bub A., Watzl B., Heeb D., Rechkemmer G., Briviba K. Malvidin-3-glucoside bioavailability in humans after ingestion of red wine, dealcoholized red wine and red grape juice. Eur. J. Nutr. 2001;40:113–120. doi: 10.1007/s003940170011.
    1. Simonetti P., Gardana C., Pietta P. Plasma levels of caffeic acid and antioxidant status after red wine intake. J. Agric. Food Chem. 2001;49:5964–5968. doi: 10.1021/jf010546k.
    1. Simonetti P., Gardana C., Pietta P. Caffeic acid as biomarker of red wine intake. Methods Enzymol. 2001;335:122–130.
    1. Caccetta R.A., Croft K.D., Beilin L.J., Puddey I.B. Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability. Am. J. Clin. Nutr. 2000;71:67–74.
    1. Nardini M., Natella F., Scaccini C., Ghiselli A. Phenolic acids from beer are absorbed and extensively metabolized in humans. J. Nutr. Biochem. 2006;17:14–22. doi: 10.1016/j.jnutbio.2005.03.026.
    1. Cartron E., Fouret G., Carbonneau M.A., Lauret C., Michel F., Monnier L., Descomps B., Léger C.L. Red-wine beneficial longterm effect on lipids but not on antioxidant characteristics in plasma in a study comparing three types of wine: Description of two O-methylated derivatives of gallic acid in humans. Free Radic. Res. 2003;37:1021–1035. doi: 10.1080/10715760310001598097.
    1. Urpi-Sarda M., Zamora-Ros R., Lamuela-Raventos R., Cherubini A., Jauregui O., de la Torre R., Covas M.I., Estruch R., Jaeger W., Andres-Lacueva C. HPLC-tandem mass spectrometric method to characterize resveratrol metabolism in humans. Clin. Chem. 2007;53:292–299.
    1. Allen N.E., Beral V., Casabonne D., Kan S.W., Reeves G.K., Brown A., Green J. Million Women Study Collaborators. Moderate alcohol intake and cancer incidence in women. J. Natl. Cancer Inst. 2009;101:296–305. doi: 10.1093/jnci/djn514.
    1. Stevens J.F., Page J.E. Xanthohumol and related prenylflavonoids from hops and beer: To your good health! Phytochemistry. 2004;65:1317–1330. doi: 10.1016/j.phytochem.2004.04.025.
    1. Miranda C.L., Stevens J.F., Ivanov V., McCall M., Frei B., Deinzer M.L., Buhler D.R. Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J. Agric. Food Chem. 2000;48:3876–3884.
    1. Rodriguez R.J., Miranda C.L., Stevens J.F., Deinzer M.L., Buhler D.R. Influence of prenylated and non-prenylated flavonoids on liver microsomal lipid peroxidation and oxidative injury in rat hepatocytes. Food Chem. Toxicol. 2001;39:437–445. doi: 10.1016/S0278-6915(00)00159-9.
    1. World Health Organization, International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Alcohol Consumption and Ethyl Carbamate. Vol. 96. IARC; Lyon, France: 2010. pp. 3–1383.
    1. Bianchini F., Vainio H. Wine and resveratrol: Mechanisms of cancer prevention? Eur. J. Cancer Prev. 2003;12:417–425. doi: 10.1097/00008469-200310000-00011.
    1. Schoonen W.M., Salinas C.A., Kiemeney L.A., Stanford J.L. Alcohol consumption and risk of prostate cancer in middle-aged men. Int. J. Cancer. 2005;113:133–140. doi: 10.1002/ijc.20528.
    1. Anderson L.A., Cantwell M.M., Watson R.G., Johnston B.T., Murphy S.J., Ferguson H.R., McGuigan J., Comber H., Reynolds J.V., Murray L.J. The association between alcohol and reflux esophagitis, barrett's esophagus, and esophageal adenocarcinoma. Gastroenterology. 2009;136:799–805.
    1. Chao C. Associations between beer, wine, and liquor consumption and lung cancer risk: A meta-analysis. Cancer Epidemiol. Biomarkers Prev. 2007;16:2436–2447. doi: 10.1158/1055-9965.EPI-07-0386.
    1. Han X., Zheng T., Foss F.M., Ma S., Holford T.R., Boyle P., Leaderer B., Zhao P., Dai M., Zhang Y. Alcohol consumption and non-hodgkin lymphoma survival. J. Cancer Surviv. 2010;4:101–109. doi: 10.1007/s11764-009-0111-4.
    1. Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., Takada Y. Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res. 2004;24:2783–2840.
    1. Guerrero R.F., Garcia-Parrilla M.C., Puertas B., Cantos-Villar E. Wine, resveratrol and health: A review. Nat. Prod. Commun. 2009;4:635–658.
    1. Seitz H.K., Pelucchi C., Bagnardi V., La Vecchia C. Epidemiology and pathophysiology of alcohol and breast cancer: Update 2012. Alcohol Alcohol. 2012;47:204–212.
    1. Coronado G.D., Beasley J., Livaudais J. Alcohol consumption and the risk of breast cancer. Salud Publica Mex. 2011;53:440–447.
    1. McCarty C.A., Reding D.J., Commins J., Williams C., Yeager M., Burmester J.K., Schairer C., Ziegler R.G. Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. Breast Cancer Res. Treat. 2012;133:785–792. doi: 10.1007/s10549-012-1972-1.
    1. Callaci J.J., Juknelis D., Patwardhan A., Sartori M., Frost N., Wezeman F.H. The effects of binge alcohol exposure on bone resorption and biomechanical and structural properties are offset by concurrent bisphosphonate treatment. Alcohol Clin. Exp. Res. 2004;28:182–191. doi: 10.1097/.
    1. Flatt S.W., Thomson C.A., Gold E.B., Natarajan L., Rock C.L., Al-Delaimy W.K., Patterson R.E., Saquib N., Caan B.J., Pierce J.P. Low to moderate alcohol intake is not associated with increased mortality after breast cancer. Cancer Epidemiol. Biomarkers Prev. 2010;19:681–688. doi: 10.1158/1055-9965.EPI-09-0927.
    1. Bessaoud F., Daures J.P. Patterns of alcohol (especially wine) consumption and breast cancer risk: A case-control study among a population in Southern France. Ann. Epidemiol. 2008;18:467–475. doi: 10.1016/j.annepidem.2008.02.001.
    1. Zamora-Ros R., Urpi-Sarda M., Lamuela-Raventos R.M., Estruch R., Vazquez-Agell M., Serrano-Martinez M., Jaeger W., Andres-Lacueva C. Diagnostic performance of urinary resveratrol metabolites as a biomarker of moderate wine consumption. Clin. Chem. 2006;52:1373–1380. doi: 10.1373/clinchem.2005.065870.
    1. Athar M., Back J.H., Tang X., Kim K.H., Kopelovich L., Bickers D.R., Kim A.L. Resveratrol: A review of preclinical studies for human cancer prevention. Toxicol. Appl. Pharmacol. 2007;224:274–283. doi: 10.1016/j.taap.2006.12.025.
    1. Renaud S., Lanzmann-Petithory D., Gueguen R., Conard P. Alcohol and mortality from all causes. Biol. Res. 2004;37:183–187.
    1. Grønbaek M.N., Sørensen T.I., Johansen D., Becker U., Gottschau A., Schnohr P., Hein H.O., Jensen G. Beer, wine, spirits and mortality. Lakartidningen. 2001;98:2585–2588.
    1. Gerloff A., Singer M.V., Feick P. Beer and its non-alcoholic compounds: Role in pancreatic exocrine secretion, alcoholic pancreatitis and pancreatic carcinoma. Int. J. Environ. Res. Public Health. 2010;7:1093–1104. doi: 10.3390/ijerph7031093.
    1. Lijinsky W. N-nitroso compounds in the diet. Mutat. Res. 1999;443:129–138.
    1. Tricker A.R., Preussmann R. Volatile and nonvolatile nitrosamines in beer. J. Cancer Res. Clin. Oncol. 1991;117:130–132. doi: 10.1007/BF01613136.
    1. Sharpe C.R., Siemiatycki J. Case-control study of alcohol consumption and prostate cancer risk in Montreal, Canada. Cancer Causes Control. 2001;12:589–598. doi: 10.1023/A:1011289108040.
    1. Jain M.G., Hislop G.T., Howe G.R., Burch J.D., Ghadirian P. Alcohol and other beverage use and prostate cancer risk among Canadian men. Int. J. Cancer. 1998;78:707–711. doi: 10.1002/(SICI)1097-0215(19981209)78:6<707::AID-IJC7>;2-2.
    1. Morales F.J., Somoza V., Fogliano V. Physiological relevance of dietary melanoidins. Amino Acids. 2012;42:1097–1109. doi: 10.1007/s00726-010-0774-1.
    1. Liegeois C., Lermusieau G., Collin S. Measuring antioxidant efficiency of wort, malt, and hops against the 2,2′-azobis(2-amidinopropane) dihydrochloride-induced oxidation of an aqueous dispersion of linoleic acid. J. Agric. Food Chem. 2000;48:1129–1134. doi: 10.1021/jf9911242.
    1. Faist V., Lindenmeier M., Geisler C., Erbersdobler H.F., Hofmann T. Influence of molecular weight fractions isolated from roasted malt on the enzyme activities of NADPH-cytochrome c-Reductase and Glutathione-S-Transferase in Caco-2 cells. J. Agric. Food Chem. 2002;50:602–606. doi: 10.1021/jf010879h.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다